已收盘 08-14 16:00:00 美东时间
+0.080
+1.03%
Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $60.000 million-$64.000 million to $62.000 million-$66.000 million vs $62.117 million estimate.
08-07 04:09
Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.63) per share which met the analyst consensus estimate. This is a 57.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $14.483 million which beat the analyst con...
08-07 04:03
Senseonics(SENS)2026年第二季度营收1450万美元,同比增长约120%;毛利率升至约59%,但净亏损扩大至3670万美元,公司同时上调全年营收及毛利率指引。
08-06 22:05
今日重点评级关注:Needham:维持Annexon"买入"评级,目标价从11美元升至25美元;Benchmark:维持Prenetics Global"买入"评级,目标价从30美元升至40美元
07-16 18:55
Mizuho analyst Anthony Petrone maintains Senseonics Holdings (NASDAQ:SENS) with a Outperform and lowers the price target from $20 to $18.
07-16 02:33
Eversense 365 CGM system demonstrated superior performance in both open-loop and closed-loop systems, with strong patient adherence and favorable glucometrics over a full year. The system achieved a mean TIR of 66.16% and GMI of 7.16%, outperforming other CGMs. Integration with the twiist AID system showed promising results, with users achieving a mean TIR of 76.08% and GMI of 6.78%. These findings highlight Eversense 365's exceptional accuracy a...
06-06 21:00
Insiders have been trading these 5 stocks: (($MPC)), (($COHR)), (($SENS)), (($K...
05-16 21:01
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
Stifel analyst Jonathan Block maintains Senseonics Holdings (NASDAQ:SENS) with a Hold and lowers the price target from $9 to $8.
05-11 21:28